NABP’s system will be unavailable from 1 PM to 6 PM on Saturday, April 26, due to infrastructure upgrades. NABP’s testing and license transfer registration, score results, CPE Monitor service, PPAD, meeting registration, and publication ordering will be unavailable during this time. Thank you for your patience.


Court Rules Off-Label Marketing Ban Violates Freedom of Speech

Topics: Prescription label

A federal appeals court overturned the conviction of a drug sales representative who marketed a product for off-label uses on grounds that the conviction violated his freedom of speech. Alfred Caronia, a former sales representative for Orphan Medical, was convicted of promoting narcolepsy drug Xyrem® for uses not approved by FDA in 2008. Caronia’s appeal was heard in the Court of Appeals for the Second Circuit in Manhattan before a three-judge panel. The court ruled in a two-to-one decision by the judges that the ban on off-label marketing violated the sales representative’s freedom of speech, reports the New York Times